RhumbLine Advisers’s Achieve Life Sciences QUIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$727K Buy
89,921
+2,898
+3% +$20.7K ﹤0.01% 2472
2026
Q2
$568K Buy
+87,023
New +$415K ﹤0.01% 2682
2025
Q2
– Sell
-42,267
Closed -$113K – 4140
2025
Q1
$113K Buy
42,267
+1,497
+4% +$4.66K ﹤0.01% 3352
2024
Q4
$144K Sell
40,770
-196
-0.5% -$888 ﹤0.01% 3357
2024
Q3
$194K Sell
40,966
-852
-2% -$3.89K ﹤0.01% 3258
2024
Q2
$197K Buy
+41,818
New +$201K ﹤0.01% 3232
2014
Q2
– Sell
-6
Closed -$148K – 3008
2014
Q1
$148K Hold
6
– – ﹤0.01% 2859
2013
Q4
$111K Hold
6
– – ﹤0.01% 2946
2013
Q3
$123K Hold
6
– – ﹤0.01% 2908
2013
Q2
$132K Buy
+6
New +$134K ﹤0.01% 3169

Other funds holding QUIT

RhumbLine Advisers's QUIT Position: Q3 2026 in Review

RhumbLine Advisers increased its Achieve Life Sciences (QUIT) stake by 3.3% in Q3 2026, buying an estimated $20.7K and bringing the position to 89,921 shares worth $727K. The position accounts for ﹤0.01% of the portfolio, ranked #2472.

RhumbLine Advisers first reported a position in QUIT in Q2 2013 and has held it in 10 quarters since. 132 funds tracked by Wall St. Rank hold QUIT as of Q3 2026.

  • RhumbLine Advisers held 89,921 shares of Achieve Life Sciences worth $727K as of Q3 2026.
  • RhumbLine Advisers bought 2,898 Achieve Life Sciences shares in Q3 2026, an estimated $20.7K.
  • Achieve Life Sciences made up ﹤0.01% of RhumbLine Advisers's portfolio in Q3 2026, its #2472 holding.
  • RhumbLine Advisers first reported a position in Achieve Life Sciences in Q2 2013 and has held it in 10 quarters since.
  • 132 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q3 2026.

Based on RhumbLine Advisers's 13F filing for Q3 2026, filed 10 Nov 2026.